...
首页> 外文期刊>Journal of Surgical Oncology >Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.
【24h】

Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.

机译:扩大食管切除术治疗胸段食管鳞状细胞癌的预后因素。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUNDS AND OBJECTIVES: In Japan, extended esophagectomy with extensive lymphadenectomy has become the standard surgical procedure for carcinoma of the thoracic esophagus. Although mortality and morbidity rates after such extensive esophagectomy have been acceptable, the long-term outcomes are not necessarily satisfactory. METHODS: Among 235 patients with primary squamous cell carcinoma of the thoracic esophagus between June 1981 and March 1998, 143 patients (60.9%) underwent extended esophagectomy with extensive lymphadenectomy. To exclude the effects of surgery-related postoperative complications, 14 patients who died within 90 days after operation were excluded. Thus, clinicopathological characteristics and prognostic factors of 129 patients were retrospectively investigated. RESULTS: Sixty-three patients were alive and free of cancer. Sixty-six patients died: 37 of recurrence of the esophageal cancer and 29 of other causes. The 1-, 3-, 5-, and 10-year overall survival rates in the 129 patients were 78.8%, 53.5%, 45.8%, and 30.9%, respectively, and the disease-specific survival rates were 85.7%, 69.1%, 67.9%, and 56.2%, respectively. The factors influencing the disease-specific survival rate were tumor location (upper third vs. non-upper third), Borrmann classification (0, 1 vs. 2, 3), size of tumor (3.0 cm), depth of invasion (T1, 2 vs. T3, 4), number of lymph node metastases (0 or 1 vs. >/=2), time of operation (420 min), amount of blood transfused (/=3 U), lymph vessel invasion (marked vs. not marked), and blood vessel invasion (marked vs. not marked). Among those significant variables, independent prognostic factors for survival determined by multivariate analysis were number of lymph node metastases (P < 0.001), amount of blood transfusions (P = 0.0016), and tumor location (P = 0.0382). CONCLUSIONS: Patients with a single metastatic node after extended esophagectomy should be considered to have excellent prognosis, like patients with pN0 tumors. Patients with multiple involved nodes should receive aggressive postoperative adjuvant treatments. Reduced blood loss during extended esophagectomy and minimal blood transfusions might improve the outcome of curative esophageal resections. Copyright 1999 Wiley-Liss, Inc.
机译:背景与目的:在日本,扩大的食管切除术和广泛的淋巴结清扫术已成为胸段食道癌的标准手术方法。尽管广泛的食管切除术后的死亡率和发病率是可以接受的,但长期结果未必令人满意。方法:在1981年6月至1998年3月的235例原发性胸段食管鳞状细胞癌患者中,有143例(60.9%)患者接受了扩大的食管切除术和广泛的淋巴结清扫术。为了排除手术相关的术后并发症的影响,排除了术后90天内死亡的14例患者。因此,对129例患者的临床病理特征和预后进行了回顾性研究。结果:63例患者还活着并且没有癌症。六十六名患者死亡:食管癌复发37例,其他原因29例。 129名患者的1年,3年,5年和10年总生存率分别为78.8%,53.5%,45.8%和30.9%,疾病特异性生存率分别为85.7%,69.1% ,67.9%和56.2%。影响疾病特异性存活率的因素包括肿瘤位置(三分之一以上/非三分之一以上),Borrmann分类(0、1 vs. 2、3),肿瘤大小( 3.0 cm) ,浸润深度(T1、2与T3、4),淋巴结转移数目(0或1对> / = 2),手术时间( 420分钟),血液量输血( / = 3 U),淋巴管浸润(标记与未标记)和血管浸润(标记与未标记)。在这些显着变量中,通过多因素分析确定的生存独立预后因素为淋巴结转移数目(P <0.001),输血量(P = 0.0016)和肿瘤位置(P = 0.0382)。结论:延长食管切除术后单发转移性淋巴结转移的患者应被认为具有良好的预后,如pN0肿瘤患者。有多个受累淋巴结的患者应接受积极的术后辅助治疗。延长食管切除术期间的失血量减少和最小限度的输血可以改善食管根治性切除的效果。版权所有1999 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号